SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-046466
Filing Date
2022-04-15
Accepted
2022-04-15 16:06:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm226283d2_s3.htm S-3 385124
2 EXHIBIT 4.6 tm226283d2_ex4-6.htm EX-4.6 317296
3 EXHIBIT 4.7 tm226283d2_ex4-7.htm EX-4.7 319419
4 EXHIBIT 5.1 tm226283d2_ex5-1.htm EX-5.1 33667
5 EXHIBIT 23.1 tm226283d2_ex23-1.htm EX-23.1 2617
6 EX-FILING FEES tm226283d2_ex107.htm EX-FILING FEES 18725
7 GRAPHIC tm226283d2_ex5-1logo.jpg GRAPHIC 2760
  Complete submission text file 0001104659-22-046466.txt   1081878
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264325 | Film No.: 22830105
SIC: 2834 Pharmaceutical Preparations